4//SEC Filing
Lambert Henry R. 4
Accession 0001209191-18-014696
CIK 0001006028other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 7:16 PM ET
Size
5.5 KB
Accession
0001209191-18-014696
Insider Transaction Report
Form 4
Lambert Henry R.
DirectorChief Executive Officer
Transactions
- Award
Stock Options (Right to Buy)
2018-02-26+200,000→ 200,000 totalExercise: $0.78Exp: 2023-02-26→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]25% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on May 26, 2018.
Documents
Issuer
PURE BIOSCIENCE, INC.
CIK 0001006028
Entity typeother
Related Parties
1- filerCIK 0001587257
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 7:16 PM ET
- Size
- 5.5 KB